J&J Defends Synthes Bid at European Union Antitrust Hearing (BusinessWeek)
Johnson & Johnson defended its planned acquisition of orthopedics maker Synthes Inc. at a meeting with European Union antitrust regulators yesterday. “There was an oral hearing,” said Antoine Colombani, a spokesman for the European Commission in Brussels. He declined to comment further. A hearing usually follows a formal antitrust complaint listing regulators’ concerns that a deal may harm competition.
The commission opened an expanded probe in November into the deal. It said at the time that the transaction...
